Study on amniotic fluid metabolism in the second trimester of Trisomy 21

BACKGROUND: Trisomy 21 is a common aneuploid condition in humans and accounts for approximately one quarter of all aneuploid live births. To date, early diagnosis of Trisomy 21 remains a challenging task. Metabolomics may prove an innovative tool to study the early pathophysiology of Trisomy 21 at a...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xiaoting, Quan, Sheng, Fu, Yurong, Wang, Weiwei, Zhang, Wenling, Wang, Xiaofei, Zhang, Chenxi, Xiang, Daijun, Zhang, Liwen, Wang, Chengbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083445/
https://www.ncbi.nlm.nih.gov/pubmed/31709651
http://dx.doi.org/10.1002/jcla.23089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083445/
https://www.ncbi.nlm.nih.gov/pubmed/31709651
http://dx.doi.org/10.1002/jcla.23089

Ejemplares similares